title: Targeting RAF-MEK-ERK kinase-scaffold interactions in cancer.
authors: Novartis Institute for Biomedical Research, Emeryville, California, USA. darrin.stuart@novartis.com
authors: Darrin D
authors: DD
authors: Stuart
authors: William R
authors: WR
authors: Sellers
mesh_terms: D000818:Animals; D006801:Humans; D020935:MAP Kinase Signaling System; D009369:Neoplasms / Q000378:metabolism*; D020703:ras GTPase-Activating Proteins / Q000378:metabolism*; D018631:ras Proteins / Q000378:metabolism*
chemical_list: C101203:IQ motif containing GTPase activating protein 1; D020703:ras GTPase-Activating Proteins; D018631:ras Proteins
references: Nature. 2010 Jan 28;463(7280):501-6
references: 20072125
references: FEBS Lett. 2009 Jun 18;583(12):1817-24
references: 19433088
references: N Engl J Med. 2012 Jul 12;367(2):107-14
references: 22663011
references: Cell Signal. 2009 Apr;21(4):462-9
references: 19091303
references: Lancet Oncol. 2013 Jan;14(1):38-47
references: 23200175
references: Nat Med. 2013 May;19(5):626-630
references: 23603816
references: Cell Signal. 2012 Apr;24(4):826-34
references: 22182509
references: Mol Cell Biol. 2005 Sep;25(18):7940-52
references: 16135787
references: Lancet Oncol. 2013 Mar;14(3):249-56
references: 23414587
references: N Engl J Med. 2012 Nov;367(18):1694-703
references: 23020132
references: N Engl J Med. 2010 Aug 26;363(9):809-19
references: 20818844
references: N Engl J Med. 2011 Feb 24;364(8):772-4
references: 21345109